By Lars Mucklejohn British Patient Capital, the venture capital subsidiary of UK government-owned British Business Bank, has invested £10m into biotech firm Curve Therapeutics to support its cancer drug discovery technology. The investment is part of a £40.5m Series A financing round for the Southampton-based company’s Microcycle drug discovery platform. Other investors include Pfizer Ventures, Columbus Venture Partners, Advent Life Sciences and Epidarex Capital. British Patient Capital said the investment would enable Curve to progress more quickly towards clinical stages and expand Microcycl…
